Nicotinamide Adenine Dinucleotide Market Size Exceed $1,722.11 Million By 2032 | CAGR: 12.41%

Nicotinamide Adenine Dinucleotide Market Size Worth $1,722.11 Million By 2032 | CAGR: 12.41%

The global nicotinamide adenine dinucleotide market size is expected to reach USD 1,722.11 million by 2032, according to a new study by Polaris Market Research. The report “Nicotinamide Adenine Dinucleotide Market Share, Size, Trends, Industry Analysis Report, By Grade (Food Grade, Pharmaceutical Grade, and Others); By Application; By Region; Segment Forecast, 2023-2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increasing product penetration as a key supplement for a variety of food ingredients because of the NAD’s antioxidant properties coupled with the surge in consumer awareness regarding the health benefits of the product and continuously growing healthcare spending capacity of people across both developed and developing countries are key factors expected to boost the market growth. Moreover, the increasing focus of major market players on developing more advanced and innovative solutions to tackle various issues associated with human health through heavily investing in R&D activities is also creating huge growth opportunities in the market.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:

NAD+ has been studied extensively across the globe over the last few decades and continues to receive current research attention as several new roles and functions of this cofactor have significantly emerged in the regulation of protein modifications that could help regulate cellular metabolism and a wide range of cellular events. Recent studies have also shown that NAD+ levels can profoundly eliminate or reduce cell damage in catabolic tissue, including the brain. Therefore, the promotion of intracellular NAD+ anabolism shows promising market growth.

Moreover, the NAD+ concentration increases under various conditions associated with reduced energy loads, including glucose deprivation, fasting, caloric restriction, and exercise. Apart from this, these levels are highly elevated under conditions of increased life span or health span, representing a major contributor to aging. Thus, supplementation with the product and its precursors might define a potential therapeutic strategy to mediate protection against the accumulation of inflammation and highly volatile ROS during aging.

Nicotinamide Adenine Dinucleotide Market Report Highlights

  • Food grade segment accounted for over considerable global market share in 2022, which is mainly accelerated by its growing adoption as a substrate across various biological processes including DNA repair
  • Dietary supplements segment dominated the global market in 2022, on account of the widespread adoption of product as an alternative for vitamins and having the ability to help in living longer and healthier lives
  • Asia Pacific region is expected to witness highest growth rate throughout the forecast period, owing to increasing consumer proliferation for improving immunization and high product adoption across the pharma sector
  • The global key market players include Jubilant Life Sciences, TCI Chemicals, Vertellus Holdings, Zhenjiang Lanbo Biotechnology, Himedia Laboratories, and Catalent.

Polaris Market Research has segmented the nicotinamide adenine dinucleotide market report based on grade, application, and region:

Nicotinamide Adenine Dinucleotide, Grade Outlook (Revenue - USD Million, 2019 - 2032)

  • Food Grade
  • Pharmaceutical Grade
  • Others

Nicotinamide Adenine Dinucleotide, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Dietary Supplements
  • Pharmaceuticals
  • Anti-aging Products
  • Others

     Nicotinamide Adenine Dinucleotide, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa